| 1 | Lung Neoplasms | 42.6% |
| 2 | Pleural Neoplasms | 42.6% |
| 3 | Bronchial Neoplasms | 33.9% |
| 4 | Pleural Effusion, Malignant | 32.7% |
| 5 | Multiple Pulmonary Nodules | 31.7% |
| 6 | Laryngeal neoplasm | 28.8% |
| 7 | Nose Neoplasms | 28% |
| 8 | Tracheitis | 27.7% |
| 9 | Tracheobronchomegaly | 27.7% |
| 10 | Parathyroid Neoplasms | 24.9% |
| 11 | Thyroid Neoplasm | 24.9% |
| 12 | Thyroid carcinoma | 24.9% |
| 13 | Abdominal Neoplasms | 22.8% |
| 14 | Soft Tissue Neoplasms | 22.8% |
| 15 | Tracheal Stenosis | 22.1% |
| 16 | Bronchitis | 21.7% |
| 17 | Paranasal Sinus Neoplasms | 21.3% |
| 18 | Mouth Neoplasms | 21.1% |
| 19 | Pleuropneumonia | 20.3% |
| 20 | Digestive System Neoplasms | 19.5% |
| 21 | Endocrine Gland Neoplasms | 19.5% |
| 22 | Eye Neoplasms | 19.5% |
| 23 | Nervous System Neoplasms | 19.5% |
| 24 | Bronchopneumonia | 19.5% |
| 25 | Esophageal Neoplasms | 19.4% |
| 26 | Bone neoplasms | 19.1% |
| 27 | Skin Neoplasms | 19.1% |
| 28 | Hematologic Neoplasms | 19.1% |
| 29 | Splenic Neoplasms | 18.9% |
| 30 | Thymus Neoplasms | 18.9% |
| 31 | Asthma | 18.8% |
| 32 | Pleurisy | 18.5% |
| 33 | Pneumonia | 18.5% |
| 34 | Lobar Pneumonia | 18.5% |
| 35 | Respiratory Distress Syndrome, Adult | 18.5% |
| 36 | Pneumonitis | 18.5% |
| 37 | Bronchitis, Chronic | 18.4% |
| 38 | Peritoneal Neoplasms | 18% |
| 39 | Maxillary Sinus Neoplasms | 17.8% |
| 40 | Thyroid Nodule | 17.6% |
| 41 | Bronchial Diseases | 17% |
| 42 | Lung diseases | 17% |
| 43 | Pleural Diseases | 17% |
| 44 | Respiration Disorders | 17% |
| 45 | Thoracic Diseases | 17% |
| 46 | Granuloma, Laryngeal | 16.8% |
| 47 | Multiple Endocrine Neoplasia | 16.5% |
| 48 | Bronchiolitis | 16.3% |
| 49 | Pancreatic Neoplasm | 16.1% |
| 50 | Laryngitis | 15.9% |
| 51 | Lung Diseases, Fungal | 15.9% |
| 52 | Rhinitis | 15.9% |
| 53 | Vocal Cord Dysfunction | 15.9% |
| 54 | Respiratory Distress Syndrome, Newborn | 15.8% |
| 55 | Paraneoplastic Encephalomyelitis | 15.8% |
| 56 | Bronchial Fistula | 15.7% |
| 57 | Lung Abscess | 15.7% |
| 58 | Tuberculosis, Pulmonary | 15.6% |
| 59 | Mammary Neoplasms, Experimental | 15.5% |
| 60 | Acanthoma | 14.6% |
| 61 | Laryngeal Diseases | 14.5% |
| 62 | Nose Diseases | 14.5% |
| 63 | Tracheal Neoplasms | 14.5% |
| 64 | Thymoma | 14.4% |
| 65 | Leukoplakia, Oral | 14.3% |
| 66 | Retroperitoneal Neoplasms | 14.3% |
| 67 | Respiratory Tract Infections | 14.2% |
| 68 | Aspergillosis, Allergic Bronchopulmonary | 14.2% |
| 69 | Granuloma, Respiratory Tract | 14% |
| 70 | Respiratory Hypersensitivity | 14% |
| 71 | Respiratory Tract Fistula | 14% |
| 72 | Choanal Atresia | 13.9% |
| 73 | Laryngocele | 13.9% |
| 74 | Sinusitis | 13.7% |
| 75 | Aspiration Pneumonia | 13.6% |
| 76 | Hamartoma | 13.5% |
| 77 | Neoplasms, Hormone-Dependent | 13.5% |
| 78 | Neoplasms, Multiple Primary | 13.5% |
| 79 | Paraneoplastic Syndromes | 13.5% |
| 80 | Precancerous Conditions | 13.5% |
| 81 | Neoplasms, Second Primary | 13.5% |
| 82 | Ear Neoplasms | 13.2% |
| 83 | Eyelid Neoplasms | 13.2% |
| 84 | Mediastinal Cyst | 13.1% |
| 85 | Pericardial Cyst | 13.1% |
| 86 | Thymic Cyst | 13.1% |
| 87 | Salivary Gland Neoplasms | 13% |
| 88 | Tongue Neoplasms | 13% |
| 89 | Palatal Neoplasms | 13% |
| 90 | Carcinoma, Lobular | 12.5% |
| 91 | Thoracic Neoplasms | 12.4% |
| 92 | Idiopathic Pulmonary Fibrosis | 12.4% |
| 93 | Testicular Neoplasms | 12.2% |
| 94 | Central Nervous System Neoplasms | 12% |
| 95 | Vascular Neoplasms | 12% |
| 96 | Pneumoconiosis | 11.9% |
| 97 | Pneumonia, Viral | 11.9% |
| 98 | Genital Neoplasms, Female | 11.9% |
| 99 | Breast Neoplasms, Male | 11.8% |
| 100 | Triple Negative Breast Neoplasms | 11.8% |
| 101 | Pneumonia, Bacterial | 11.7% |
| 102 | Pharyngeal Neoplasms | 11.6% |
| 103 | Laryngospasm | 11.6% |
| 104 | Hyaline Membrane Disease | 11.5% |
| 105 | Asthma, Exercise-Induced | 11.5% |
| 106 | Status Asthmaticus | 11.5% |
| 107 | Carcinoma, Pancreatic Ductal | 11.3% |
| 108 | Cyst | 11.2% |
| 109 | Neoplastic Processes | 11.2% |
| 110 | Neoplastic Syndromes, Hereditary | 11.2% |
| 111 | Pregnancy Complications, Neoplastic | 11.2% |
| 112 | Pneumonia, Lipid | 11.2% |
| 113 | Neoplasms, Experimental | 11.1% |
| 114 | Altitude Sickness | 11% |
| 115 | Atelectasis | 11% |
| 116 | Bronchospasm | 11% |
| 117 | Bronchiectasis | 11% |
| 118 | Chylothorax | 11% |
| 119 | Hydropneumothorax | 11% |
| 120 | Hydrothorax | 11% |
| 121 | Pulmonary Hypertension | 11% |
| 122 | Pneumothorax | 11% |
| 123 | Pulmonary Alveolar Proteinosis | 11% |
| 124 | Pulmonary Edema | 11% |
| 125 | Pulmonary Fibrosis | 11% |
| 126 | Respiratory Insufficiency | 11% |
| 127 | Bronchial Hyperreactivity | 11% |
| 128 | Hamman-Rich syndrome | 11% |
| 129 | Lung Diseases, Interstitial | 11% |
| 130 | Respiratory Depression | 11% |
| 131 | Lung Diseases, Obstructive | 11% |
| 132 | Respiratory Failure | 11% |
| 133 | Scimitar Syndrome | 11% |
| 134 | Meningioma | 10.9% |
| 135 | Multiple Endocrine Neoplasia Type 1 | 10.8% |
| 136 | Acute Chest Syndrome | 10.7% |
| 137 | Meconium Aspiration Syndrome | 10.7% |
| 138 | Primary Ciliary Dyskinesia | 10.6% |
| 139 | Bronchiolitis Obliterans | 10.6% |
| 140 | Adrenal Gland Neoplasms | 10.3% |
| 141 | Gastrointestinal Neoplasms | 10.3% |
| 142 | Genital Neoplasms, Male | 10.3% |
| 143 | Head and Neck Neoplasms | 10.3% |
| 144 | Liver neoplasms | 10.3% |
| 145 | Uveal Neoplasms | 10.3% |
| 146 | Asthma, Occupational | 10.3% |
| 147 | Urologic Neoplasms | 10.2% |
| 148 | Radiation Pneumonitis | 10.2% |
| 149 | Radiation Fibrosis | 10.2% |
| 150 | Sebaceous Gland Neoplasms | 10.1% |
| 151 | Spinal Neoplasms | 10.1% |
| 152 | Bone Marrow Neoplasms | 10.1% |
| 153 | Tracheomalacia | 10% |
| 154 | Rhinoscleroma | 9.9% |
| 155 | Liver Neoplasms, Experimental | 9.7% |
| 156 | Asbestosis | 9.7% |
| 157 | Berylliosis | 9.7% |
| 158 | Silicosis | 9.7% |
| 159 | Carcinoma 256, Walker | 9.6% |
| 160 | Acoustic Neuroma | 9.5% |
| 161 | Neoplasms, Radiation-Induced | 9.5% |
| 162 | Hoarseness | 9.5% |
| 163 | Farmer's Lung | 9.3% |
| 164 | Granuloma, Lethal Midline | 9.2% |
| 165 | Laryngeal Edema | 9.2% |
| 166 | Nose Deformities, Acquired | 9.2% |
| 167 | Lung Injury | 9.2% |
| 168 | Hepatopulmonary Syndrome | 9.2% |
| 169 | Respiratory Aspiration | 9.2% |
| 170 | Kartagener Syndrome | 9.2% |
| 171 | Hypopharyngeal Neoplasms | 9.2% |
| 172 | Hypopharyngeal Cancer | 9.2% |
| 173 | Vipoma | 9.2% |
| 174 | Paraneoplastic Cerebellar Degeneration | 9.2% |
| 175 | insulinoma | 9.2% |
| 176 | Hay fever | 9.1% |
| 177 | Rhinitis, Allergic, Perennial | 9.1% |
| 178 | Apnea | 9.1% |
| 179 | Cheyne-Stokes Respiration | 9.1% |
| 180 | Common Cold | 9.1% |
| 181 | Dyspnea | 9.1% |
| 182 | Hemothorax | 9.1% |
| 183 | Hyperventilation | 9.1% |
| 184 | Influenza | 9.1% |
| 185 | Mouth Breathing | 9.1% |
| 186 | Tachypnea | 9.1% |
| 187 | Catarrh | 9.1% |
| 188 | Parotid Neoplasms | 9.1% |
| 189 | Carcinoma, Ehrlich Tumor | 9.1% |
| 190 | Dermoid Cyst | 9.1% |
| 191 | Pulmonary Embolism | 9.1% |
| 192 | Carcinoma, Lewis Lung | 9.1% |
| 193 | Pulmonary Eosinophilia | 9.1% |
| 194 | Severe Acute Respiratory Syndrome | 9.1% |
| 195 | Eosinophilic Pneumonia | 9.1% |
| 196 | Laryngopharyngeal Reflux | 9.1% |
| 197 | Gastrinoma | 9% |
| 198 | Glucagonoma | 9% |
| 199 | Asthma, Aspirin-Induced | 9% |
| 200 | Trophoblastic Neoplasms | 8.8% |
| 201 | Leukemia, Experimental | 8.7% |
| 202 | Tuberous Sclerosis | 8.7% |
| 203 | Tracheal Diseases | 8.5% |
| 204 | Pituitary Adenoma | 8.5% |
| 205 | Pituitary Neoplasms | 8.5% |
| 206 | Melanoma, Experimental | 8.5% |
| 207 | Retinoblastoma | 8.5% |
| 208 | Meningeal Neoplasms | 8.4% |
| 209 | Hepatocellular Adenoma | 8.4% |
| 210 | Nephroblastoma | 8.3% |
| 211 | Airway Obstruction | 8.2% |
| 212 | Choking | 8.2% |
| 213 | Epiglottitis | 8.2% |
| 214 | Chronic Obstructive Airway Disease | 8.2% |
| 215 | Mediastinitis | 8.2% |
| 216 | Middle Lobe Syndrome | 8.2% |
| 217 | Acute Lung Injury | 8.2% |
| 218 | Limbic Encephalitis | 8.1% |
| 219 | Neoplasms, Neuroepithelial | 8.1% |
| 220 | Gliomatosis cerebri | 8.1% |
| 221 | Tonsillar Neoplasms | 8.1% |
| 222 | Blastomycosis | 8% |
| 223 | Pharyngitis | 8% |
| 224 | Neuroectodermal Tumors | 7.9% |
| 225 | Laryngostenosis | 7.9% |
| 226 | Nasal Polyps | 7.9% |
| 227 | Leydig Cell Tumor | 7.9% |
| 228 | ovarian neoplasm | 7.9% |
| 229 | Hemoptysis | 7.8% |
| 230 | Optic Nerve Glioma | 7.8% |
| 231 | Pertussis | 7.8% |
| 232 | Sarcoma, Experimental | 7.7% |
| 233 | Leukemia, Radiation-Induced | 7.7% |
| 234 | Erythroplasia | 7.6% |
| 235 | Follicular cyst | 7.6% |
| 236 | leukemia | 7.6% |
| 237 | Mucocele | 7.6% |
| 238 | Neoplasms, Germ Cell and Embryonal | 7.6% |
| 239 | Neoplasms, Glandular and Epithelial | 7.6% |
| 240 | Pilonidal Cyst | 7.6% |
| 241 | Thyroglossal Cyst | 7.6% |
| 242 | Synovial Cyst | 7.6% |
| 243 | Germ Cell Cancer | 7.6% |
| 244 | Aberrant Crypt Foci | 7.6% |
| 245 | Lambert-Eaton Myasthenic Syndrome | 7.4% |
| 246 | Prolactinoma | 7.4% |
| 247 | Growth Hormone-Secreting Pituitary Adenoma | 7.4% |
| 248 | Nasopharyngeal Neoplasms | 7.4% |
| 249 | Nasopharyngeal carcinoma | 7.3% |
| 250 | Brain Neoplasms | 7.2% |
| 251 | Spinal Cord Neoplasms | 7.2% |
| 252 | Medulloblastoma | 7.2% |
| 253 | melanoma | 7.1% |
| 254 | Uterine Neoplasms | 7.1% |
| 255 | Vaginal Neoplasms | 7.1% |
| 256 | Vulvar Neoplasms | 7.1% |
| 257 | Uterine Cancer | 7.1% |
| 258 | Fallopian Tube Neoplasms | 7.1% |
| 259 | Cystic Fibrosis | 7% |
| 260 | Voice Disorders | 6.9% |
| 261 | Voice Disturbance | 6.9% |
| 262 | Epistaxis | 6.9% |
| 263 | Persistent Fetal Circulation Syndrome | 6.9% |
| 264 | Croup | 6.8% |
| 265 | Histiocytosis, Langerhans-Cell | 6.8% |
| 266 | Mediastinal Emphysema | 6.8% |
| 267 | Rhinitis, Vasomotor | 6.8% |
| 268 | Pulmonary Aspergillosis | 6.8% |
| 269 | Bronchopulmonary Aspergillosis | 6.8% |
| 270 | Hypoventilation | 6.8% |
| 271 | Pulmonary Emphysema | 6.8% |
| 272 | Acidosis, Respiratory | 6.7% |
| 273 | Alkalosis, Respiratory | 6.7% |
| 274 | Carcinosarcoma | 6.7% |
| 275 | Hemangiosarcoma | 6.7% |
| 276 | Leukemia L1210 | 6.7% |
| 277 | Leukemia P388 | 6.7% |
| 278 | lymphangiosarcoma | 6.7% |
| 279 | Sarcoidosis, Pulmonary | 6.7% |
| 280 | Sleep Apnea Syndromes | 6.7% |
| 281 | Opsoclonus-Myoclonus Syndrome | 6.7% |
| 282 | Pulmonary Infarction | 6.7% |
| 283 | Meningeal Carcinomatosis | 6.7% |
| 284 | Choriocarcinoma | 6.7% |
| 285 | granulosa cell tumor | 6.6% |
| 286 | Carcinoma, Ovarian Epithelial | 6.6% |
| 287 | Adenomatous Polyposis Coli | 6.5% |
| 288 | Leukoplakia | 6.4% |
| 289 | Lymphocele | 6.4% |
| 290 | Pancreatic Cyst | 6.4% |
| 291 | Central Nervous System Cysts | 6.4% |
| 292 | Bile Duct Neoplasms | 6.3% |
| 293 | gallbladder neoplasm | 6.3% |
| 294 | Intestinal Neoplasms | 6.3% |
| 295 | Penile Neoplasms | 6.3% |
| 296 | Prostatic Neoplasms | 6.3% |
| 297 | Stomach Neoplasms | 6.3% |
| 298 | Barrett Esophagus | 6.3% |
| 299 | Breast Cyst | 6.3% |
| 300 | Histiocytic Disorders, Malignant | 6.3% |
| 301 | Actinic keratosis | 6.3% |
| 302 | Neoplasm Invasiveness | 6.3% |
| 303 | Neoplasm Metastasis | 6.3% |
| 304 | Neoplasm Recurrence, Local | 6.3% |
| 305 | Parovarian Cyst | 6.3% |
| 306 | Carcinogenesis | 6.3% |
| 307 | Myxoid cyst | 6.3% |
| 308 | Metastasis | 6.3% |
| 309 | Mesoblastic Nephroma | 6.3% |
| 310 | Lymphomatoid Granulomatosis | 6.2% |
| 311 | Polycythemia Vera | 6.2% |
| 312 | Sarcoma 180 | 6.2% |
| 313 | Adenoma, Acidophil | 6.2% |
| 314 | Ganglioneuroma | 6.2% |
| 315 | Glioma | 6.2% |
| 316 | Malignant Glioma | 6.2% |
| 317 | Laryngomalacia | 6.1% |
| 318 | Myelitis, Transverse | 6.1% |
| 319 | Vocal Cord Paralysis | 6.1% |
| 320 | Basal Cell Nevus Syndrome | 5.9% |
| 321 | Adrenocortical carcinoma | 5.9% |
| 322 | Composite Lymphoma | 5.9% |
| 323 | Tonsillitis | 5.8% |
| 324 | Dyspnea, Paroxysmal | 5.8% |
| 325 | Respiratory Paralysis | 5.8% |
| 326 | Granulomatosis with polyangiitis | 5.8% |
| 327 | Leukemia, Plasma Cell | 5.7% |
| 328 | Supratentorial Neoplasms | 5.7% |
| 329 | Carcinoid Tumor | 5.7% |
| 330 | Endometrial Neoplasms | 5.7% |
| 331 | Neurilemmoma | 5.7% |
| 332 | Hutchinson's Melanotic Freckle | 5.7% |
| 333 | Melanoma, Amelanotic | 5.7% |
| 334 | Bronchopulmonary Dysplasia | 5.6% |
| 335 | Basal cell carcinoma | 5.6% |
| 336 | Carcinoma, Papillary | 5.6% |
| 337 | Squamous cell carcinoma | 5.6% |
| 338 | Chondrosarcoma | 5.6% |
| 339 | Craniopharyngioma | 5.6% |
| 340 | Cystadenoma | 5.6% |
| 341 | leiomyosarcoma | 5.6% |
| 342 | liposarcoma | 5.6% |
| 343 | Mesothelioma | 5.6% |
| 344 | synovial sarcoma | 5.6% |
| 345 | Neuroectodermal Tumor, Melanotic | 5.6% |
| 346 | Angiomyolipoma | 5.6% |
| 347 | Clear Cell Sarcoma of Soft Tissue | 5.6% |
| 348 | Alveolar Soft Part Sarcoma | 5.6% |
| 349 | Neuroendocrine Tumors | 5.6% |
| 350 | Sarcoma, Myeloid | 5.6% |
| 351 | Carcinoma, Basal Cell | 5.6% |
| 352 | Sleep Apnea, Obstructive | 5.6% |
| 353 | Sleep Apnea, Central | 5.6% |
| 354 | Bladder Neoplasm | 5.6% |
| 355 | Kidney Neoplasm | 5.6% |
| 356 | Ureteral Neoplasms | 5.6% |
| 357 | Urethral Neoplasms | 5.6% |
| 358 | Lymphoma | 5.4% |
| 359 | Corpus Luteum Cyst | 5.3% |
| 360 | Ovarian Cysts | 5.3% |
| 361 | Renal Cell Carcinoma | 5.2% |
| 362 | Papillary Renal Cell Carcinoma | 5.2% |
| 363 | Astrocytoma | 5.2% |
| 364 | Ependymoma | 5.2% |
| 365 | oligodendroglioma | 5.2% |
| 366 | Ganglioglioma | 5.2% |
| 367 | gliosarcoma | 5.2% |
| 368 | Anaplastic astrocytoma | 5.2% |
| 369 | Anaplastic Oligodendroglioma | 5.2% |
| 370 | Aphonia | 5% |
| 371 | Retropharyngeal Abscess | 5% |
| 372 | Dysphonia | 5% |
| 373 | Anti-Glomerular Basement Membrane Disease | 5% |
| 374 | Bronchomalacia | 5% |
| 375 | Cystadenocarcinoma | 5% |
| 376 | Fibrosarcoma | 5% |
| 377 | Osteosarcoma | 5% |
| 378 | Mucoepidermoid Carcinoma | 5% |
| 379 | Prostatic Neoplasms, Castration-Resistant | 5% |
| 380 | Brain Stem Neoplasms | 5% |
| 381 | Nelson Syndrome | 5% |
| 382 | Malignant Carcinoid Syndrome | 4.9% |
| 383 | Transfusion-Related Acute Lung Injury | 4.9% |
| 384 | Invasive Pulmonary Aspergillosis | 4.8% |
| 385 | Adenoma | 4.8% |
| 386 | Ameloblastoma | 4.8% |
| 387 | Angiokeratoma | 4.8% |
| 388 | Carcinoma | 4.8% |
| 389 | Chordoma | 4.8% |
| 390 | Hemangioma | 4.8% |
| 391 | hemangiopericytoma | 4.8% |
| 392 | Lymphangioma | 4.8% |
| 393 | Mesenchymoma | 4.8% |
| 394 | Nevus | 4.8% |
| 395 | Teratoma | 4.8% |
| 396 | Hepatoblastoma | 4.8% |
| 397 | Mixed Tumor, Mullerian | 4.8% |
| 398 | Germinoma | 4.8% |
| 399 | Teratocarcinoma | 4.8% |
| 400 | Angiofibroma | 4.8% |
| 401 | Sarcoma | 4.8% |
| 402 | Epithelioma | 4.8% |
| 403 | Carcinoma, Endometrioid | 4.7% |
| 404 | Adenofibroma | 4.7% |
| 405 | Fibroadenoma | 4.7% |
| 406 | Malignant Fibrous Histiocytoma | 4.7% |
| 407 | Choledochal Cyst | 4.7% |
| 408 | Glioblastoma | 4.7% |
| 409 | Neuroblastoma | 4.7% |
| 410 | Glioblastoma Multiforme | 4.7% |
| 411 | Peutz-Jeghers Syndrome | 4.6% |
| 412 | Choroid Plexus Papilloma | 4.6% |
| 413 | Denys-Drash Syndrome | 4.6% |
| 414 | Endometrial Stromal Sarcoma | 4.5% |
| 415 | Nasopharyngitis | 4.5% |
| 416 | Ganglioneuroblastoma | 4.5% |
| 417 | Bowen's Disease | 4.4% |
| 418 | Paraganglioma | 4.4% |
| 419 | Rhabdomyosarcoma | 4.4% |
| 420 | Giant Cell Tumor of Bone | 4.4% |
| 421 | Cecal Neoplasms | 4.4% |
| 422 | Duodenal Neoplasms | 4.4% |
| 423 | Cerebellar Neoplasms | 4.3% |
| 424 | Hydatidiform Mole | 4.3% |
| 425 | Neurofibrosarcoma | 4.2% |
| 426 | Dermatofibrosarcoma | 4.2% |
| 427 | Dermatofibrosarcoma Protuberans | 4.2% |
| 428 | Peritonsillar Abscess | 4.1% |
| 429 | Lymphangioleiomyomatosis | 4.1% |
| 430 | Carcinoid Heart Disease | 4.1% |
| 431 | Pancreatic Pseudocyst | 4% |
| 432 | Plasmacytoma | 4% |
| 433 | Colorectal Neoplasms | 4% |
| 434 | Malignant histiocytosis | 3.9% |
| 435 | Lymphatic Metastasis | 3.9% |
| 436 | Neoplasms, Unknown Primary | 3.9% |
| 437 | Leukemic Infiltration | 3.9% |
| 438 | Histiocytic sarcoma | 3.9% |
| 439 | Neoplasm Micrometastasis | 3.9% |
| 440 | Pheochromocytoma | 3.9% |
| 441 | Alveolar rhabdomyosarcoma | 3.9% |
| 442 | Appendiceal Neoplasms | 3.8% |
| 443 | Colonic Neoplasms | 3.8% |
| 444 | Rectal Neoplasms | 3.8% |
| 445 | Eosinophilic Granuloma | 3.7% |
| 446 | Adenocarcinoma | 3.4% |
| 447 | Carcinoma in Situ | 3.4% |
| 448 | Carcinoma, Transitional Cell | 3.4% |
| 449 | Phyllodes Tumor | 3.4% |
| 450 | Dysgerminoma | 3.4% |
| 451 | Hemangioendothelioma | 3.4% |
| 452 | Lipoma | 3.4% |
| 453 | Myoma | 3.4% |
| 454 | Myxoma | 3.4% |
| 455 | Neuroma | 3.4% |
| 456 | Papilloma | 3.4% |
| 457 | Pseudomyxoma Peritonei | 3.4% |
| 458 | Seminoma | 3.4% |
| 459 | Papillomatosis | 3.4% |
| 460 | Angiolipoma | 3.4% |
| 461 | Myelolipoma | 3.4% |
| 462 | Neoplasms, Bone Tissue | 3.4% |
| 463 | Neoplasms, Fibrous Tissue | 3.4% |
| 464 | Smooth Muscle Tumor | 3.4% |
| 465 | Adenomatosis, Pulmonary | 3.4% |
| 466 | Adenomatous Polyps | 3.4% |
| 467 | Carcinoma, Large Cell | 3.4% |
| 468 | Carcinoma, Small Cell | 3.4% |
| 469 | Desmoplastic Small Round Cell Tumor | 3.4% |
| 470 | Chondroma | 3.4% |
| 471 | Enchondroma | 3.4% |
| 472 | Hodgkin Disease | 3.3% |
| 473 | Lymphoma, Non-Hodgkin | 3.3% |
| 474 | Polycystic Ovary Syndrome | 3.3% |
| 475 | Anus Neoplasms | 3.2% |
| 476 | Sigmoid Neoplasms | 3.2% |
| 477 | Xeroderma Pigmentosum | 3.1% |
| 478 | Primary amyloidosis | 2.9% |
| 479 | Leukemia, Myelomonocytic, Chronic | 2.8% |
| 480 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.8% |
| 481 | Adenoid Cystic Carcinoma | 2.7% |
| 482 | fibroma | 2.7% |
| 483 | Fibromatosis | 2.7% |
| 484 | Osteoblastoma | 2.7% |
| 485 | Osteoma | 2.7% |
| 486 | Rhabdomyoma | 2.7% |
| 487 | Chondromatosis | 2.7% |
| 488 | Adenocarcinoma, Clear Cell | 2.7% |
| 489 | Cholangiocarcinoma | 2.7% |
| 490 | Cervical Intraepithelial Neoplasia | 2.7% |
| 491 | Hemangioblastoma | 2.7% |
| 492 | Lymphoma, Extranodal NK-T-Cell | 2.7% |
| 493 | Mastocytosis | 2.4% |
| 494 | Sturge-Weber Syndrome | 2.4% |
| 495 | Cell Transformation, Viral | 2.4% |
| 496 | Gastrointestinal Stromal Tumors | 2.4% |
| 497 | Hemangioma, Cavernous | 2.4% |
| 498 | Leukemia, T-Cell | 2.4% |
| 499 | Leukemia, B-Cell | 2.4% |
| 500 | neurofibroma | 2.4% |
| 501 | Lymphoma, Follicular | 2.4% |
| 502 | T-Cell Lymphoma | 2.4% |
| 503 | Mantle cell lymphoma | 2.4% |
| 504 | Fibromatosis, Aggressive | 2.4% |
| 505 | Fibromatosis, Abdominal | 2.4% |
| 506 | Klatskin Tumor | 2.4% |
| 507 | Waldenstrom Macroglobulinemia | 2.3% |
| 508 | Multiple Myeloma | 2.3% |
| 509 | Mastocytoma | 2.2% |
| 510 | Mastocytosis, Systemic | 2.2% |
| 511 | Leukemia, Myeloid, Chronic-Phase | 2.2% |
| 512 | Zollinger-Ellison syndrome | 2.1% |
| 513 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.9% |
| 514 | Leukemia, Large Granular Lymphocytic | 1.9% |
| 515 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.9% |
| 516 | Lymphoma, T-Cell, Cutaneous | 1.9% |
| 517 | Lymphoma, AIDS-Related | 1.9% |
| 518 | Enteropathy-Associated T-Cell Lymphoma | 1.9% |
| 519 | Primary Effusion Lymphoma | 1.9% |
| 520 | Dupuytren Contracture | 1.7% |
| 521 | Urticaria Pigmentosa | 1.7% |
| 522 | Mycosis Fungoides | 1.6% |
| 523 | Lymphomatoid Papulosis | 1.6% |
| 524 | Plasmablastic lymphoma | 1.6% |
| 525 | Burkitt Lymphoma | 1.5% |
| 526 | Sezary Syndrome | 1.3% |
| 527 | Radicular Cyst | 1.3% |